Safety and efficacy of intravenous administration of bone-marrow derived mesenchymal stromal cells in therapy refractory juvenile idiopathic arthritis patients, a phase IB/IIA pilot-study

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2018
This article has no abstract
Epistemonikos ID: 8c2f8207875a168ca3d3b4707c98333ecdc9b071
First added on: Feb 09, 2025